Ambry Genetics
Commercial clinical laboratory Ambry Genetics of Aliso Viejo,
Calif., and RainDance Technologies Inc. of Lexington, Mass., have jointly announced
their partnership in using the latter’s RDT 1000 instrument for sequence enrichment
and resequencing validation. Researchers can use the device and the former company’s
services to reduce study time by running samples more quickly. The latter company
provides instruments, consumables and reagents for sequence enrichment, ultradeep
sequencing and methylation analysis.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024